167 related articles for article (PubMed ID: 18384651)
1. A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion.
Shlansky-Goldberg RD; Matsumoto AH; Baumbach GA; Siegel JB; Raabe RD; Murphy TP; Deng C; Ray Dawkins J; Marder VJ
J Thromb Haemost; 2008 Jun; 6(6):944-50. PubMed ID: 18384651
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 study of human plasma-derived plasmin (TAL-05-00018) in hemodialysis graft occlusion.
Shlansky-Goldberg R
Thromb Res; 2008; 122 Suppl 3():S16-9. PubMed ID: 18760830
[TBL] [Abstract][Full Text] [Related]
3. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
Marder VJ; Comerota AJ; Shlansky-Goldberg RD; Davis JP; Deng C; Hanna K; Fineberg D
J Thromb Haemost; 2012 Jun; 10(6):985-91. PubMed ID: 22487025
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator.
Marder VJ
Thromb Res; 2008; 122 Suppl 3(Suppl 3):S9-S15. PubMed ID: 18722003
[TBL] [Abstract][Full Text] [Related]
5. Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage.
Stewart D; Kong M; Novokhatny V; Jesmok G; Marder VJ
Blood; 2003 Apr; 101(8):3002-7. PubMed ID: 12446443
[TBL] [Abstract][Full Text] [Related]
6. Plasmin (Human) Administration in Acute Middle Cerebral Artery Ischemic Stroke: Phase 1/2a, Open-Label, Dose-Escalation, Safety Study.
Mitchell PJ; Yan B; Brozman M; Ribo M; Marder V; Courtney KL; Saver JL;
J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):308-320. PubMed ID: 27793534
[TBL] [Abstract][Full Text] [Related]
7. Pulse-spray pharmacomechanical thrombolysis of thrombosed hemodialysis access grafts: long-term experience and comparison of original and current techniques.
Valji K; Bookstein JJ; Roberts AC; Oglevie SB; Pittman C; O'Neill MP
AJR Am J Roentgenol; 1995 Jun; 164(6):1495-500; discussion 1501-3. PubMed ID: 7754901
[TBL] [Abstract][Full Text] [Related]
8. Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.
Hoefer IE; Stroes ES; Pasterkamp G; Levi MM; Reekers JA; Verhagen HJ; Meijers JC; Humphries JE; Rotmans JI
J Vasc Interv Radiol; 2009 Jul; 20(7):951-8. PubMed ID: 19481472
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis with plasmin: implications for stroke treatment.
Marder VJ; Jahan R; Gruber T; Goyal A; Arora V
Stroke; 2010 Oct; 41(10 Suppl):S45-9. PubMed ID: 20876504
[TBL] [Abstract][Full Text] [Related]
10. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
[TBL] [Abstract][Full Text] [Related]
11. Thrombolysis of occluded femoropopliteal graft with locally delivered human plasmin.
Nenezić D; Radak D; Gajin P; Tanasković S; Novaković A; Matić P
Srp Arh Celok Lek; 2014; 142(5-6):342-6. PubMed ID: 25033592
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic potency of acid-stabilized plasmin: superiority over tissue-type plasminogen activator in an in vitro model of catheter-assisted thrombolysis.
Novokhatny V; Taylor K; Zimmerman TP
J Thromb Haemost; 2003 May; 1(5):1034-41. PubMed ID: 12871374
[TBL] [Abstract][Full Text] [Related]
13. Hydrodynamic thrombectomy system versus pulse-spray thrombolysis for thrombosed hemodialysis grafts: a multicenter prospective randomized comparison.
Barth KH; Gosnell MR; Palestrant AM; Martin LG; Siegel JB; Matalon TA; Goodwin SC; Neese PA; Swan TL; Uflacker R
Radiology; 2000 Dec; 217(3):678-84. PubMed ID: 11110928
[TBL] [Abstract][Full Text] [Related]
14. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
[TBL] [Abstract][Full Text] [Related]
15. Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development.
Landskroner K; Olson N; Jesmok G
J Vasc Interv Radiol; 2005 Mar; 16(3):369-77. PubMed ID: 15758133
[TBL] [Abstract][Full Text] [Related]
16. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?
Novokhatny VV; Jesmok GJ; Landskroner KA; Marder VJ; Zimmerman TP
Trends Pharmacol Sci; 2004 Feb; 25(2):72-5. PubMed ID: 15102492
[TBL] [Abstract][Full Text] [Related]
17. Original report. Pulse-spray thrombolysis of thrombosed hemodialysis grafts with tissue plasminogen activator.
Cooper SG
AJR Am J Roentgenol; 2003 Apr; 180(4):1063-6. PubMed ID: 12646455
[TBL] [Abstract][Full Text] [Related]
18. Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.
Kandadai MA; Meunier JM; Hart K; Holland CK; Shaw GJ
Transl Stroke Res; 2015 Feb; 6(1):78-87. PubMed ID: 25411015
[TBL] [Abstract][Full Text] [Related]
19. Dimerized plasmin fragment D as a potential biomarker to predict successful catheter-directed thrombolysis therapy in acute deep vein thrombosis.
Luo CM; Wu IH; Chan CY; Chen YS; Yang WS; Wang SS
Phlebology; 2015 Oct; 30(9):620-6. PubMed ID: 25297982
[TBL] [Abstract][Full Text] [Related]
20. Structure and activity of plasmin and other direct thrombolytic agents.
Novokhatny V
Thromb Res; 2008; 122 Suppl 3():S3-8. PubMed ID: 18718639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
